Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer

Bioconjugate Chemistry

Volumn 16, Issue 6, 2005, Pages 1580-1588

  Liu, Shuang ^a   Hsieh, Wen Yuan ^a   Kim, Young Seung ^a   Mohammed, Sulma I ^b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEXATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TUMORS;

ARG GLY ASPS; ATHYMIC; BENZENESULFONIC ACID; BIODISTRIBUTIONS; CO-LIGANDS; ISONICOTINIC ACID; LIGAND COMPLEXES; NUDE MICE; PYRIDINEDICARBOXYLIC ACIDS; TRIPHENYL PHOSPHINES;

LIGANDS;

6 HYDRAZINONICOTINIC ACID; ARGINYLGLYCYLASPARTIC ACID; CYCLIC PEPTIDE RGDFK; CYCLOPEPTIDE; DIMER; INTEGRIN; ISOCINCHOMERONIC ACID; ISONICOTINIC ACID; LIGAND; NICOTINIC ACID; SQ 168; SULFONIC ACID DERIVATIVE; TECHNETIUM 99M; TRISODIUM TRIPHENYLPHOSPHINE 3,3',3'' TRISULFONATE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; [2 [[[5 (CARBONYL) 2 PYRIDINYL]HYDRAZONO]METHYL]BENZENESULFONIC ACID]GLUTAMYL[CYCLO(LYSYLARGINYLGLYCYLASPARTYLPHENYLALANYL)CYCLO(LYSYLARGINYLGLY CYLASPARTYLPHENYLALANINAMIDE)];

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CONJUGATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHILICITY; LIGAND BINDING; LIVER; MOUSE; NONHUMAN; TUMOR LOCALIZATION; TUMOR XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

EID: 27944436169     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0501653     Document Type: Article

References (47)

1. 99mTc-Labeling of a hydrazinonicotinamide- conjugated vitronectin receptor antagonist useful for imaging tumor. Bioconjugate Chem. 12, 624-629.
2. 3 integrin binding peptides in a nude mouse model. Cancer Res. 62, 6146-6151.
3. 64Cu-labeled dimeric RGD peptides. Mol. Imag. Biol. 6, 350-359.
4. 177Lu-labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy. Bioconjugate Chem. 12, 559-568.
5. Janssen, M. L., Frielink, C., Dijkgraaf, I., Oyen, W. J., Edwards, D. S., Liu, S., Rajopadhye, M., Massuger, L. F., Corstens, F. H., and Boerman, O. C. (2004) Improved tumor targeting of radiolabeled RGD-peptides using rapid dose fractionation. Cancer Biother. Radiopharm. 19, 399-404.
6. 90Y- labeled DOTA-biomolecule conjugates using gentisic acid and ascorbic acid. Bioconjugate Chem. 12, 554-558.
7. 111In labeled DTPA-peptide conjugates. Bioconjugate Chem. 12, 630-634.
8. Liu, S., and Edwards, D. S. (2002) Fundamentals of receptor-based diagnostic metalloradiopharmaceuticals. Topics Curr. Chem. 222, 259-278.
9. 3 directed radiopharmaceuticals for tumor imaging. Drugs Future 28, 551-564.
10. 3 antagonists as radiopharmaceuticals for tumor radiotherapy. Topics Curr. Chem. 252, 193-216.
11. 99mTc. Bioconjugate Chem. 8, 146-154.
12. 99mTc. Bioconjugate Chem. 8, 155-160.
13. 99mTc-labeling of hydrazinonicotinamide-modified biologically active molecules using imine-N containing heterocycles as coligands. Bioconjugate Chem. 9, 583-595.
14. Edwards, D. S., Liu, S., Ziegler, M. C., Harris, A. R., Crocker, A. C., Heminway, S. J., Barrett, J. A., Bridger, G. J., Abrams, M. J., and Higgins, J. D. (1999) RP463: A stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging. Bioconjugate Chem. 10, 884-891.
15. m-labeled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits. Nucl. Med. Commun. 21, 1043-1050.
16. 4 receptor antagonist useful for imaging infection and inflammation. Bioconjugate Chem. 13, 881-886.
17. van Eerd, J. E. M., Oyen, W. J. G., Harris, T. D., Rennen, H. J. J. M., Edwards, D. S.; Liu, S., Ellars, C. E., Corstens, F. H. M., and Boerman, O. C. (2003) A bivalent leukotriene B4 antagonist for scintigraphic imaging of infectious foci. J. Nucl. Med. 44, 1087-1091.
18. 2 formulation for RP444: a new radiopharmaceutical for thrombus imaging. J. Pharm. Sci. 90, 114-123.
19. Liu, S., Edwards, D. S., Harris, A. R., Heminway, S. J., and Barrett, J. A. (1999) Technetium complexes of a hydrazinonicotinamide-conjugated cyclic peptide and 2-hydrazinopyridine: Synthesis and characterization. Inorg. Chem. 38, 1326-1335.
20. 99mTc-labeled bioconjugates. Bioconjugate Chem. 11, 113-117.
21. 99mTc-labeling of small biomolecules. Topics Curr. Chem. 252, 117-153.
22. 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. Nucl. Med. Biol. 22, 25-30.
23. 4N)} core. Inorg. Chim. Acta 309, 123-136.
24. 3S modified RC-160 and [Tyr3]octreotide. Bioconjugate Chem. 10, 431-438.
25. Decristoforo, C., and Mather, S. J. (1999) Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence. Eur. J. Nucl. Med. 26, 869-876.
26. 99mTc-labeled peptide-HYNIC conjugates: effect of lipophilicity and stability on biodistribution. Nucl. Med. Biol. 26, 389-396.
27. 3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled antisense DNA. Eur. J. Nucl. Med. 27, 1700-1707.
28. Rennen, H. J. J. M., van Eerd, J. E., Oyen, W. J. G., Corstens, F. H. M., Edwards, D. S., and Boerman, O. C. (2002) Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection. Bioconjugate Chem. 13, 370-377.
29. Laverman, P., Béhé, M., Oyen, W. J. G., Willems, P. H. G. M., Corstens, F. H. M., Behr, T. M., and Boerman, O. C. (2004) Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors. Bioconjugate Chem. 15, 561-568.
30. 99mTc-labeled hydrazine nicotinamide derivatized polypeptides and peptides. Nucl. Med. Biol. 28, 155-164.
31. 99mTc-labeled polypeptides with low in vivo protein binding. Nucl. Med. Biol. 28, 215-224.
32. 99mTc-HYNIC-labeled polypeptides derived with ternary ligand complexes. Bioconjugate Chem. 13, 491-501.
33. 3 antagonists. J. Am. Chem. Soc. 118, 7461-7472.
34. 99mTc-labeled radiopharmaceuticals. Bioconjugate Chem. 10, 808-814,
35. Hoffman, R. M. (2002) Green fluorescent protein imaging of tumor growth, metastasis, and angiogenesis in mouse models. The Lancet Oncol. 3, 546-556.
36. Yang, M., Baranov, E., Li, X. M., Wang, J. W., Jiang P., Li, L., Moossa, A. R., Penman, S., and Hoffman, R. M. (2001) Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc. Natl. Acad. Sci. U.S.A. 98, 2616-2621.
37. 64Cu-labeled RGD peptide. Bioconjugate Chem. 15, 41-49.
38. 64Cu-labeled tetrameric RGD peptide. J. Nucl. Med. 46, 1707-1718.
39. 3 expression. Nuklearmedizin 43, 26-32.
40. 3-integrin in lung and other organs. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L217-L226.
41. Babich, J. W., Solomon, H., Pike, M. C., Kroon, D., Graham, W., Abrams, M. J., Tompkins, R. G., Rubin, R. H., and Fischman, A. J. (1993) Technetium-99m labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. J. Nucl. Med. 34, 1964-1974.
42. 111In IgG. Nucl. Med. Biol. 22, 643-648.
43. 111In-Octreotide. J. Nucl. Med. 41, 1114-119.
44. 1-octreotide. Eur. J. Nucl. Med. 27, 628-637.
45. 111In-labeled octreotide derivatives. Eur. J. Nucl. Med. 27, 1318-1325,
46. Hnatowich, D. J., Winnard P. Jr., Virzi, F., Fogarasi, M., Santo, T., Smith, C. L., Cantor, C. R., and Rusckowski, M. (1995) Technetium-99m labeling of DNA oligonucleotides. J. Nucl. Med. 36, 2306-2314.
47. 99mTc-HYNIC- folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging, J. Nucl. Med. 40, 1563-1569.